ArticleFrontiers in pharmacology2026

Druggable Mendelian randomization prioritizes CDH2 and supports finerenone as a candidate therapeutic strategy for diabetic retinopathy.

Xiangyang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.